Summary of Meeting Information

Conference Theme: Forum on Promoting the Research and Development of Topical Preparations

Explore new trends and jointly build new peaks

Meeting Time: March 14, 2024, 09:00-12:00

Meeting Venue: 3rd Floor, Doubletree by Hilton Hangzhou Heda, Venue 2

Organizer: Gaomai Pharmaceutical, Pharmaceutical Future Hub

Background and purpose of the meeting

With the rapid development of the global pharmaceutical industry, topical skin preparations have become a hot topic in the pharmaceutical field. 

Topical preparations have multiple advantages, including huge market potential, direct drug effects, relatively high safety, short research and development cycles, diverse product forms, convenience for patients to use, and benefits for brand building, etc. These advantages have made topical preparations one of the important product lines for pharmaceutical enterprises, providing strong support for their development.

Meanwhile, the research and development technology of topical preparations is also constantly advancing. From traditional ointments and emulsions to modern transdermal absorption systems and nano-drug carriers, the dosage forms of topical preparations have become increasingly diverse, and drug release and control technologies have also become increasingly precise. This provides more possibilities for drug developers, but also brings greater challenges.

This "Topical Formulation R&D Forum" aims to build a professional communication platform, inviting industry experts, scholars, enterprise representatives, etc. to jointly discuss the R&D trends, market status quo and future development directions of topical formulations. By sharing the latest research and development achievements, exchanging advanced research and development concepts and technical means, we promote exchanges and cooperation in the field of topical formulation research and development. Meanwhile, we also hope that through this forum, we can expand opportunities for R&D cooperation, promote the deep integration of the upstream and downstream of the industrial chain, and jointly drive the healthy development of the external preparation drug market.